Ameriprise’s NRX Pharmaceuticals NRXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.13M Buy
1,415,212
+486,484
+52% +$1.73M ﹤0.01% 2669
2026
Q2
$3.8M Buy
+928,728
New +$3.07M ﹤0.01% 2737

Other funds holding NRXP

Ameriprise's NRXP Position: Q3 2026 in Review

Ameriprise increased its NRX Pharmaceuticals (NRXP) stake by 52% in Q3 2026, buying an estimated $1.73M and bringing the position to 1,415,212 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

Ameriprise first reported a position in NRXP in Q2 2026 and has held it in 2 quarters since. 50 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.

  • Ameriprise held 1,415,212 shares of NRX Pharmaceuticals worth $4.13M as of Q3 2026.
  • Ameriprise bought 486,484 NRX Pharmaceuticals shares in Q3 2026, an estimated $1.73M.
  • NRX Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2669 holding.
  • Ameriprise first reported a position in NRX Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 50 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.